Company Data
GRI Bio Inc.
Ticker
GRI
Current Price
$2.3 -28.12%
Market Cap
$1.2M
Price Target
Refer to Report
Volume
11.5M
52wk Range
$3.05 - $172.4905
Overview
Vallon Pharmaceuticals Inc is a biopharmaceutical company, which focuses on the development and commercialization of proprietary biopharmaceutical products. The company develops prescription drugs for central nervous system disorders. Its product ADAIR, a proprietary, abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder, and narcolepsy.